Congress investigating Bayer advertising claims
Pharma Compliance Alert, October 22, 2008
Representatives John Dingell (D-MI) and Bart Stupak (D-MI) continue to examine pharmaceutical direct-to-consumer advertising, this time taking aim at Bayer Aspirin with Heart Advantage.
Bayer claims the product reduces the risk of heart attack by up to 30% and contains a natural plant-based supplement clinically proven to lower bad (LDL) cholesterol, which may help reduce the risk of heart disease.
Dingell and Stupak want to know why Bayer ignored the FDA’s 2000 warning not to promote products that combine over-the-counter drugs and dietary supplements because the addition of the supplement could affect the safety and effectiveness of the drug. In a letter to Bayer President Gary Balkima, the representatives requested copies of documents relating to claims about the supplement and the combination product as well as results of all studies.
- Knew about Bayer’s product in advance of the marketing
- Knows about any other combination products being marketed
- Has made any recent decisions regarding the marketing of combination products
Comments
0 comments on “Congress investigating Bayer advertising claims ”
Related Products
-
Healthcare Life Safety Compliance
Learn Life Safety Code tips and interpretations for healthcare facilities with this in-depth monthly resource.
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Medical Environment Update
Timely medical compliance news from OSHA, CDC, EPA, and other regulatory agencies!
-
Bloodborne Pathogens Training Video
Meets OSHA requirements for training employees on the bloodborne pathogens standard!
-
Complete Guide to Lab Safety, 3rd Ed.
The third edition of this popular resource makes training and compliance easier by consolidating regulations from all...
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- Running an effective peer review committee meeting
- HealthDataInsights posts new issues for medical necessity claims
- Sneak Peek: Effort underway to establish caseload benchmarks
- Q/A: Coding for telescopic intraocular lens
- New FAQ posted on storing laryngoscope blades
- Tip: Perform your own internal investigation prior to government audit
- HIPAA 5010 deadline extended, but threat remains, says AMA
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- E-mailed
-
- Running an effective peer review committee meeting
- HIPAA Q&A: Flu shot requirement for hospital employees
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- Q/A: Coding for telescopic intraocular lens
- Q/A: Correct use of modifier -PT
- Tip: Correctly code bilateral pain management procedures
- "Wall fountains" may be spreading Legionnaires to patients, visitors
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- COT basics to best
- Searched